http://content.nejm.org/cgi/content/full/354/14/1445
"The concern of the advisory committee reflected several considerations. The cardiovascular effects of the sympathomimetic amines have been thoroughly described in the medical literature. These agents substantially increase the heart rate and blood pressure. In a placebo-controlled trial, mixed amphetamine salts (Adderall) administered to adults increased systolic blood pressure by about 5 mm Hg; similar effects were found with methylphenidate formulations.2 Blood-pressure changes of this magnitude, particularly during long-term therapy, are known to increase morbidity and mortality. In 2005, a separate FDA advisory committee that I chaired concluded that blood-pressure changes represented such a reliable predictor of cardiovascular outcomes that class labeling would be appropriate in most cases.3 The increases in heart rate induced by sympathomimetic agents also have well-described adverse cardiovascular effects. The administration of these drugs produces persistent increases in heart rate, inducing chronic heart failure in animal models of dilated cardiomyopathy."
"The concern of the advisory committee reflected several considerations. The cardiovascular effects of the sympathomimetic amines have been thoroughly described in the medical literature. These agents substantially increase the heart rate and blood pressure. In a placebo-controlled trial, mixed amphetamine salts (Adderall) administered to adults increased systolic blood pressure by about 5 mm Hg; similar effects were found with methylphenidate formulations.2 Blood-pressure changes of this magnitude, particularly during long-term therapy, are known to increase morbidity and mortality. In 2005, a separate FDA advisory committee that I chaired concluded that blood-pressure changes represented such a reliable predictor of cardiovascular outcomes that class labeling would be appropriate in most cases.3 The increases in heart rate induced by sympathomimetic agents also have well-described adverse cardiovascular effects. The administration of these drugs produces persistent increases in heart rate, inducing chronic heart failure in animal models of dilated cardiomyopathy."
Vastaukset 2
Vanhimmat
She is back!!
Jokaisen kun pitää kumminkin kuolla.
Mutta ennen sitä elämässä on muutakin kuin sydän- ja verisuonitautien pelkääminen. Onneksi se ei taida kovin monelle ADHD-henkilölle edes pälkähtää heidän ampiaispesäaivoihin. Jos sille ampiaispesälle jotakin voidaan ja ihminen siitä hyötyy, niin se on paljon se.
ADHD-henkilöt sitäpaitsi taitavat kuolla muutenkin aiemmin kun muut, sillä heitä on syönyt eläimellinen stressi.
Duodecimin päätoimittajaa lainatakseni, sydän- ja verisuonitauteihin on hyvä kuolla, kun asia on kerrasta poikki.